These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11724505)

  • 1. State of percutaneous transluminal coronary artery angioplasty and effectiveness of low-density lipoprotein apheresis.
    Miyamoto T; Niwa A; Sinoda T
    Ther Apher; 2001 Aug; 5(4):226-31. PubMed ID: 11724505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
    Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E
    Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
    Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
    Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART).
    Yamaguchi H; Lee YJ; Daida H; Yokoi H; Miyano H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F
    Chem Phys Lipids; 1994 Jan; 67-68():399-403. PubMed ID: 8187240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of restenosis after coronary angioplasty with low-density lipoprotein apheresis.
    Adachi H; Niwa A; Shinoda T
    Artif Organs; 1995 Dec; 19(12):1243-7. PubMed ID: 8967882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with Abciximab: early and six-month outcome.
    Murdock DK; Logemann T; Hoffmann MT; Olson KJ; Engelmeier RS
    Cathet Cardiovasc Diagn; 1997 Oct; 42(2):173-9. PubMed ID: 9328702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent.
    Moer R; Myreng Y; Mølstad P; Albertsson P; Gunnes P; Lindvall B; Wiseth R; Ytre-Arne K; Kjekshus J; Golf S
    J Am Coll Cardiol; 2001 Nov; 38(6):1598-603. PubMed ID: 11704369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial.
    Cox DA; Stone GW; Grines CL; Stuckey T; Cohen DJ; Tcheng JE; Garcia E; Guagliumi G; Iwaoka RS; Fahy M; Turco M; Lansky AJ; Griffin JJ; Mehran R;
    J Am Coll Cardiol; 2003 Sep; 42(6):971-7. PubMed ID: 13678914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of in-stent restenosis with excimer laser coronary angioplasty.
    Karaca I; Ilkay E; Akbulut M; Yavuzkir M
    Jpn Heart J; 2003 Mar; 44(2):179-86. PubMed ID: 12718480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apheresis technology for prevention and regression of atherosclerosis.
    Yamamoto A; Harada-Shiba M; Kawaguchi A; Tsushima M
    Ther Apher; 2001 Aug; 5(4):221-5. PubMed ID: 11724504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
    Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
    N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.